Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CD69 | Q07108 | 1/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.37 |
| ▸ | AMY2A | P04746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12214020 | 1.00 | LGALS3 (0.43) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL16683264 | 0.93 | LGALS3 (0.41) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL27316161 | 0.89 | LGALS3 (0.41) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL18589695 | 0.88 | LGALS3 (0.47) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL14091725 | 0.88 | LGALS3 (0.47) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL2602688 | 0.86 | LGALS3 (0.49) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL16659352 | 0.86 | LGALS3 (0.45) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL18589697 | 0.86 | LGALS3 (0.45) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL15274901 | 0.86 | LGALS3 (0.45) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL25121361 | 0.86 | MAPK1 (0.44) | LGALS3LGALS8LGALS4MAPK1CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023201336-A2 | HUMANIZED MULTIVALENT PROTEIN CONJUGATES | VALITOR, INC. (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023201337-A2 | METHOD OF TREATING UVEITIS WITH MULTIVALENT PROTEIN-HYALURONIC ACID POLYMER CONJUGATE | VALITOR, INC. (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023201335-A2 | PURIFIED MULTIVALENT PROTEIN-HYALURONIC ACID POLYMER CONJUGATES | VALITOR, INC. (US) | 2023-10-19 | — | — | WO | disclosed |